While orforglipron succeeded in a Phase 3 trial, its weight loss effects were more modest than investors and analysts ...

In the mirror photo, Depp, 26, wore a sheer black minidress draped over a matching white lace bra and underwear set, with her ...

Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) fell 13.9% in the afternoon session after its oral weight-loss ...

Eli Lilly & Co.’s experimental pill helped patients shed roughly 11% of their body weight, about 25 pounds, in a late-stage ...

A transformative moment in the global fight against obesity has emerged with the announcement of positive topline results ...

A new daily weight loss pill could be available soon – and a recent trial has shown that people taking the drug can shed ...

A creditor is claiming at least $8.6 million damages in alleging racketeering and wire fraud by companies, colleges and ...

Eli Lilly (LLY) reported $15.56 billion in revenue for the quarter ended June 2025, representing a year-over-year increase of 37.6%. EPS of $6.31 for the same period compares to $3.92 a year ago. The ...

The past week saw market turbulence, with President Trump's new gold tariffs, Eli Lilly's dramatic stock drop, a weakening ...

Freakier Friday brings back Lindsay Lohan and Jamie Lee Curtis in a sequel that doubles the chaos of the 2003 hit.

Shares of Eli Lilly & Co. suffered their biggest selloff in 26 years on Thursday, after the drug giant disclosed late-stage trial data for its weight-loss pill that fell well short of expectations.